On Sunday, March 18th REGENXBIO will be participating in the Rock ‘n’ Roll D.C. event benefiting the National MPS Society. A cross-functional group of 50 REGENXBIO team members will represent the company in the 5K and the half-marathon event. 

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO is investigating RGX-111 and RGX-121, potential one-time gene therapies, for the treatment of MPSI and MPS II respectively. 

Employees participating in the half-marathon event are as follows:

Ben Heithoff, Elad Firnberg, Erika Gaglione, Juan Carlos Ramos, Sarah Bien, Vivienne Xiong and Ye Liu

Employees participating in the 5K event are as follows: 

Akanksha Kaushal, Akriti Virdi, Alexander Bailey, Alicia Hoffman, Beril Ozden, Brad Hollidge, Casey Chapman, Cathy Gibson, Chen Wang, Corina Giron, Dominique Jefferson, Erika Kane, Hamidah Yakasai, Hayley Carroll, Matthew Duff, Janet Yu, Jonathan Anthony, John Drugan, John Salim, Joshua Holley, Kelly Snyder, Kendra Hill, Kirsten Cowley, Kristin Leach, Laura Pisani, Leiby Soto, Matthieu Guibert, Mike Gillmeister, Mina Staveley, Nick Bourbeau, Niutish Bastani, Raza Zaidi, Rolane Qian, Ron Stehman, Ryan Clarke, Sajini Randeniya, Sheyla Finkner, Tom Smith, Valeria Mora, Vitaliy Bondar, Win Cheung, Yanhong Wei.

Visit this link to support the runners. 

Note: Please leave a note indicating which REGENXBIO participant you are donating on behalf of. Thank you!